Clinical Trial

Inova Cardiogenic Shock Registry (INOVA SHOCK)

Study acronym: INOVASHOCK
Recruiting
View on ClinicalTrials.gov →
Summary
To collect retrospective clinical outcomes related to acute decompensated heart failure cardiogenic shock, acute myocardial infarction cardiogenic shock and compare current versus historical survival rates. To collect Inova Heart and Vascular Institute (IHVI) site specific outcomes before and after initiation of the Cardiogenic Shock team on January 1, 2017. To collect outcomes related to implementation of mechanical circulatory support versus no circulatory intervention and type of intervention (extracorporeal membrane oxygenation (ECMO) versus intracorporeal axial-flow (Impella). • Assess survival at three time points.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2017-12-14; most recent amendment 2026-03-12.
Status change: Not Yet Recruiting → Recruiting 2019-02-18
Trial Details
NCT Number NCT03378739
Lead Sponsor Inova Health Care Services
Conditions Cardiogenic Shock
Enrollment 3,000 participants
Start Date 2018-01-01
Primary Completion 2099-12-31 (estimated)
Study Completion 2099-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-16